Skip to search formSkip to main contentSkip to account menu

2 ML Adenosine 3 MG/ML Injection

Known as: ADENOSINE 3MG/ML INJ VIL 2ML, ADENOSINE 3 mg in 1 mL INTRAVENOUS INJECTION, adenosine 3 mg in 1 mL INTRAVENOUS INJECTION_#3 
National Institutes of Health

Related topics

Related topics

18 relations
2 ML Adenosine 3 MG/ML Prefilled SyringeAdenosineAdenosine Receptor Agonists [MoA]Atrial Fibrillation

Broader (1)

Anti-Arrhythmia Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Solid‐Phase Synthesis of Oligo‐ADP‐Ribose
Solid‐phase methodology for synthesis of adenosine diphosphate ribose oligomers (ADPr‐oligomers) of defined length is described… 
2015
2015
TCT-299 Adenosine Versus Regadenoson In Assessing Fractional Flow Reserve, A Meta Analysis
2013
2013
Observation of curative effect of ara-adenosine on the hand-foot-mouth disease in children
Objective:To explore the curative effect of injection Ara - adenosine on infants with hand - foot - mouth disease(HFMD). Eighty… 
1997
1997
특별강연 ( 1997 . 11. 14 ) : A3 아데노신 수용체 (Adenosine Receptor)에 대한 선택적 리간드의 개발
1995
1995
P076 Adenosine triphosphate(ATP)の冠動脈内投与による冠血流増加・心筋虚血軽減作用
1954
1954
Results of treatment of calcific tendinitis with adenosine 5-monophosphate: preliminary report.
1954
1954
Results of treatment of calcific tendinitis with adenosine 5-monophosphate: preliminary report.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)